The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksResolute Mining Regulatory News (RSG)

Share Price Information for Resolute Mining (RSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 24.60
Bid: 24.00
Ask: 24.60
Change: 1.60 (7.05%)
Spread: 0.60 (2.50%)
Open: 23.40
High: 24.80
Low: 23.40
Prev. Close: 22.70
RSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Rule 8.3- Reliance Security

6 Jul 2007 12:02

Octopus Investments Limited06 July 2007 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the Takeover Code) 1. KEY INFORMATION Name of person dealing (Note 1) Octopus Investments Ltd Company dealt in Reliance Security Group plc Class of relevant security to which Ordinary shares of 5p the dealings being disclosed relate (Note 2) Date of dealing 4 July 2007 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevantsecurity dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 260,648 1.21% Nil (2) Derivatives (other than options) Nil Nil (3) Options and agreements to Nil Nilpurchase/sell Total 260,648 1.21% Nil (b) Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities Nil Nil (2) Derivatives (other than options) Nil Nil (3) Options and agreements to Nil Nilpurchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) Sale 1500 840p (b) Derivatives transactions (other than options) Product Long/short Number of Price per name, e.g. (Note 6) securities unit (Note 5)CFD (Note 7) (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, Expiry Option name,e.g. selling, securities price e.g. date money call purchasing, to which American, paid/ option varying the option European received etc. relates etc. per unit (Note 7) (Note 5) (ii) Exercising Product name, Number of Exercise price per unit e.g. call option securities (Note 5) (d) Other dealings (including new securities) (Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. .............................................................................. Is a Supplemental Form 8 attached? (Note 9) NO Date of disclosure 5 July 2007 Contact name Chris Hulatt Telephone number 020 7710 2804 If a connected EFM, name of offeree /offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Apr 20247:07 amRNSMarch 2024 Quarterly Presentation
30th Apr 20247:07 amRNSMarch 2024 Quarterly Activities Report
26th Apr 20247:00 amRNSQuarterly Conference Call Details
23rd Apr 20247:25 amRNSAGM Notice of Access
23rd Apr 20247:19 amRNSNotice of Annual General Meeting
27th Mar 202412:04 pmRNSCorporate Governance Statement
27th Mar 202412:03 pmRNSAppendix 4G
27th Mar 202411:55 amRNS2023 Annual Report
26th Mar 20247:00 amRNSAGM Advanced Notice
25th Mar 20247:00 amRNSAppendix 3Z Mark Potts
25th Mar 20247:00 amRNSAppendix 3X Adrienne Parker
21st Mar 20247:00 amRNSDirector Changes
8th Mar 20247:00 amRNSOre Reserves and Mineral Resource Statement
29th Feb 20247:00 amRNSAppendix 4E & Preliminary Final Report
31st Jan 20248:01 amRNSDec-23 Quarterly Activity Report and 2024 Guidance
29th Jan 20247:00 amRNSQuarterly Conference Call Details
24th Jan 20247:00 amRNSMaiden Mineral Resource at Tomboronkoto
11th Jan 20248:00 amRNSChange of Company Secretary
30th Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:00 amRNSSeptember 2023 Quarterly Activities Report
26th Oct 20237:00 amRNSQuarterly Conference Call Details
13th Oct 20237:38 amRNSGroup 3 Year Forecast and Update to 2023 Guidance
5th Sep 20237:00 amRNSChange of Share Registry Address
4th Sep 20237:00 amRNSMineral Resources Increased at Syama North Project
29th Aug 20237:00 amRNSChange of Registered Office
22nd Aug 20237:55 amRNSSummary of Half Year Results
22nd Aug 20237:50 amRNSHalf Yearly Results and Accounts
27th Jul 20237:00 amRNSJune 2023 Quarterly Activities Report
25th Jul 20237:00 amRNSQuarterly Conference Call Details
19th Jun 20237:00 amRNSAppendix 3X - KEITH MARSHALL
19th Jun 20237:00 amRNSDirector appointment
25th May 20238:32 amRNSDetails of Voting at Annual General Meeting
2nd May 20237:00 amRNS2022 Sustainability Report
27th Apr 20237:00 amRNSMarch 2023 Quarterly Activities Report
20th Apr 20239:14 amRNSQuarterly Conference Call Details
18th Apr 20238:20 amRNSAGM Notice of Access
18th Apr 20238:17 amRNSNotice of Annual General Meeting
5th Apr 20237:00 amRNSAGM Advanced Notice
29th Mar 20237:00 amRNSReport on Payments to Governments
29th Mar 20237:00 amRNSAppendix 4G
29th Mar 20237:00 amRNSCorporate Governance Statement
29th Mar 20237:00 amRNS2022 Annual Report
8th Mar 20237:00 amRNSOre Reserves and Mineral Resource Statement
24th Feb 20237:00 amRNSPreliminary Financial Results Presentation
24th Feb 20237:00 amRNS2022 Preliminary Financial Results
24th Feb 20237:00 amRNSAppendix 4E Preliminary Final Report
23rd Feb 20237:00 amRNSPreliminary Results Conference Call Details
6th Feb 20237:00 amRNSMining Indaba Presentation
3rd Feb 20237:00 amRNSAppointment of Chief Financial Officer
31st Jan 20237:00 amRNSDecember 2022 Quarterly Results and CY23 Guidance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.